NF-κB downregulates BACE1 to reduce Aβ, inflammatory factors including TNF-α, IL-6, IL-12, and tau phosphorylation via Cdk5/P25, which could be abnormally activated in AD. The gene discussed is MAPT; the disease is Alzheimer disease.